ReDuNing, a patented Chinese medicine, reduces the susceptibility to H1N1 influenza of mice loaded with restraint stress

European Journal of Integrative Medicine

Volumn 6, Issue 6, 2014, Pages 637-645

  Tang, Lu Ping ^a   Mao, Zhong Fu ^a   Li, Xiao Xiao ^a   Chen, Min ^a   Li, Shan Bing ^a   Tsoi, Bun ^a   Cao, Ling Fang ^a   Li, Ling ^a   Zeng, Ji Mei ^a   Wang, Zhi Wei ^a   Yu, Gui Yuan ^a   Xiao, Wei ^b   Li, Yi Fang ^a   Kurihara, Hiroshi ^a   He, Rong Rong ^a  

^a JINAN UNIVERSITY   (China)

^b State Key Laboratory of New tech for Chinese Medicine Pharmaceutical Process   (China)

Author keywords

Influenza virus; Pneumonia; ReDuNing; Restraint stress

Indexed keywords

ANTIVIRUS AGENT; BIOLOGICAL MARKER; CHINESE DRUG; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON INDUCIBLE TRANSMEMBRANE 3; INTERLEUKIN 1BETA; MESSENGER RNA; MITOCHONDRIAL ANTIVIRAL SIGNALING PROTEIN; NUCLEOPROTEIN; REDUNING; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; BODY WEIGHT; CHINESE MEDICINE; HISTOPATHOLOGY; IMMOBILIZATION STRESS; INFECTION SENSITIVITY; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H1N1 3; MORTALITY; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

EID: 85027950222     PISSN: 18763820     EISSN: 18763839     Source Type: Journal    
DOI: 10.1016/j.eujim.2014.07.018     Document Type: Article

References (39)

1. Rothberg M.B., Haessler S.D. Complications of seasonal and pandemic influenza. Crit Care Med 2010, 38:91-97.
2. Wright P.F. Kawaoka NGY: Orthomyxoviruses. Fields Virol 2007, 14:1691-1740.
3. Sebastian U., Paul S. An update on swine-origin influenza virus A/H1N1. Virus Genes 2009, 39:279-292.
4. Dawood F.S., Jain S., Finelli L., Shaw M.W., Shaw M.W., Lindstrom S., Garten R.J., Gubareva L.V., Xu X., Bridges C.B., Uyeki T.M. Emergence of a novel swine origin influenza A (H1N1) virus in humans. N Engl J Med 2009, 360:2605-2615.
5. Cheng K.F., Leung P.C. What happened in China during the 1918 influenza pandemic. Int Infect Dis 2007, 11:360-364.
6. Zhong N.S., Li Y.M., Yang Z.F., Wang C., Liu Y.N., Li X.W., Shu L.Y., Wang G.F. Chinese guidelines for diagnosis and treatment of influenza. JTD 2011, 3:274-289.
7. Wang C.Z., Li P., Yuan C.S. Traditional Chinese herbal therapy as a treatment option for H1N1 influenza. Ann Intern Med 2012, 156:166-167.
8. Ling C.G. Effect of RDN on aging pneumonic. Guide Chin Med 2010, 8:453-454.
9. Villarino M., Sandin-Espana P., Melgarejo P. High Chlorogenic and neochlorogenic acid levels in immature peaches reduce Monilinia laxa infection by interfering with fungal melanin biosynthesis. J Agric Food Chem 2011, 59:3205-3213.
10. Hao B.J., Wu Y.H., Wang J.G., Hu S.Q., Keil D.J., Hu H.J., Zhao Y. Hepatoprotective and antiviral properties of isochlorogenic acid A from Laggera alata against hepatitis B virus infection. J Ethnopharmacol 2012, 144:190-194.
11. Fleming D.M., Elliot A.J. The impact of influenza on the health and health care utilization of elderly people. Vaccine 2005, 23:1-9.
12. Glaser R., Kiecolt-Glaser J.K. Science and society stress-induced immune dysfunction: implications for health. Nat Rev Immunol 2005, 5:243-251.
13. He R.R., Wang M., Wang C.Z., Chen B.T., Liu C.L., Yao X.S., Chen J.X., Hiroshi Kurihara Protective effect of apple polyphenols against stress-provoked influenza viral infection in restraint mice. J Agric Food Chem 2011, 9:3730-37375.
14. Cao H.J., Tan R.R., He R.R., Tang L.P., Wang X.L., Yao N., Duan W.J., Hu Y.A., Yao X.S., Hiroshi Kurihara Sarcandra glabra extract reduces the susceptibility and severity of influenza in restraint-stressed mice. Evidence Based Complement Altern 2012, 10:1155-1167.
15. Mori K., Kido T., Daikuhara H., Sakakibara I., Sakata T., Shimizu K., Amagaya S., Sasaki H., Komatsu Y. Effect of Hochuekki- to (TJ-41), a Japanese herbal medicine, on the survival of mice infected with influenza virus. Antiviral Res 1999, 44:103-111.
16. Ruigrok R.W., Crepin T., Hart D.J., Cusack S. Towards an atomic resolution understanding of the influenza virus replication machinery. Curr Opin Struct Biol 2010, 20:104-113.
17. Ferreira J.F.S., Luthria D.L., Sasaki T. Flavonoids from Artemisia annua L. as antioxidants and their potential synergism with artemisinin against malaria and cancer. Molecules 2010, 15(5):3135-3170.
18. Lee S.J., Sun P., Ko J.H., et al. Glycoprotein isolated from Gardenia jasminoides Ellis has a scavenging activity against oxygen radicals and inhibits the oxygen radical-induced protein kinase C alpha and nuclear factor-kappa B in NIH/3T3 cells. Environ Toxicol Pharmacol 2006, 21(1):8-21.
19. Fuentes E., Caballerro J., Alarcon M., Rojas A., Palomo I. Chlorogenic acid inhibits human platelet activation and thrombus formation. PLoS One 2014, 9(3):e90699.
20. Hwang S.J., Kim Y.W., Park Y. Anti-inflammatory effects of chlorogenic acid in lipopolysaccharide-stimulated RAW 264.7 cells. Inflamm Res 2014, 63(1):81-90.
21. Liu M.J., Song S.X., Li H.R. The protective effect of caffeic acid against inflammation injury of primary bovine mammary epithelial cells induced by lipopolysaccharide. J Dairy Sci 2014, 97(5):2856-2865.
22. Zuo L., Chen Y.L., Zhang W.H. Reduning injection inhibits replication and proliferation of mouse cytomegalovirus and down-regulates the expressions of IFN-gamma and IL-6 in mouse cytomegalovirus pneumonia. Chin J Cell Mol Immunol 2013, 29(12):1242-1244.
23. Wan Q., Yan S.Q., Deng Y.P. Clinical observation on Reduning injection and ganciclovir in treatment of children with infectious mononucleosis. Chin J Hosp Pharm 2013, 33(16):1349-1350.
24. Fukuyama S., Kawaoka Y. The pathogenesis of influenza virus infections: the contributions of virus and host factors. Curr Opin Immunol 2011, 23:481-486.
25. Belser J.A., Wadford D.A., Pappas C. Pathogenesis of pandemic influenza A (H1N1) and triple-reassortant swine influenza A (H1) viruses in mice. J Virol 2010, 84:4194-4203.
26. Jong M.D., Simmons C.P., Thanh T.T., Hien V.M., Smith G.J., Hoang D.M., Chau N.V.V., Khanh T.H., Dong V.C., Qui P.T., Van C.B., Ha D.Q., Guan Y., Peiris J.S.M., Chinh N.T., Hien T.T., Farrar J. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006, 12:1203-1207.
27. Hendrik P., Michael B., Olaf G., Poeck H., Bscheider M., Gross O., Finger K., Roth S., Rebsamen M., Hannesschlager N., Schlee M., Rothenfusser S., Barchet W., Kato H., Akira S., Inoue S., Endres S., Peschel C., Hartmann G., Hornung V., Ruland J. Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production. Nat Immunol 2010, 11:1763-1824.
28. Penghua W., Alvaro A., Zhang Y., Sultana H., Dai J.F., Yang L., LeBlanc P.M., Doiron K., Saleh M., Fikrig E. Caspase-12 controls West Nile virus infection via the viral RNA receptor RIG-I. Nat Immunol 2010, 11:912-961.
29. Sun Q.M., Sun L.J., Liu H.H., Chen X., Seth R.B., Forman J., Chen Z.J.J. The specific and essential role of MAVS in antiviral innate immune responses. Immunity 2006, 24:633-642.
30. Flory E., Kunz M., Scheller C., Jassoy C., Stauber R., Rapp U.R., Ludwig S. Influenza virus induced NF-kappa B-dependent gene expression is mediated by over expression of viral proteins and involves oxidative radicals and activation of I kappa B kinase. J Biol Chem 2000, 275:8307-8314.
31. McCarty M.F., Barroso-Arand J., Contreras F. Practical strategies for targeting NF-kappa B and NADPH oxidase may improve survival during lethal influenza epidemics. Med Hypotheses 2010, 74:18-20.
32. Wei L., Sandbulte M.R., Thomas P.G., Webby R.J., Homayouni R., Pfeffer L.M. NF-kappa B negatively regulates interferon-induced gene expression and anti-influenza activity. J Biol Chem 2006, 281:11678-11684.
33. Bernasconi D., Amici C., La F.S., Ianaro A. The I kappa B kinase is a key factor in triggering influenza A virus-induced inflammatory cytokine production in airway epithelial cells. J Biol Chem 2005, 280:24127-24134.
34. Rehwinkel J., Sousa C.R. Rigorous detection exposing virus through RNA sensing. Science 2010, 327:284-286.
35. Lazear H.M., Lancaster A., Wilkins C., Suthar M.S., Huang A., Vick S.C., Clepper L., Thackray L., Brassil M.M., Virgin H.W., Nikolich-Zugich J., Moses A.V., Gale M., Fruh K., Diamond M.S. IRF-3, IRF-5, and IRF-7 coordinately regulate the type I IFN response in myeloid dendritic cells downstream of MAVS signaling. PLoS Pathog 2013, 9:118-127.
36. Biacchesi S., Merour E., Lamoureux A., Bernard J., Bremont M. Both STING and MAVS fish orthologs contribute to the induction of interferon mediated by RIG-I. PLoS One 2012, 7:47737-47745.
37. Fukuyama S., Kawaoka Y. The pathogenesis of influenza virus infections: the contributions of virus and host factors. Curr Opin Immunol 2011, 2:481-486.
38. Eric M., Jennifer S., Sinu P., Chin C.R., Pertel T., Chen L.M., Gaiha G.D., Ryan B.J., Donis R.O., Elledge S.J., Brass A.L. IFITM3 inhibits influenza A virus infection by preventing cytosolic entry. PLOS Pathog 2011, 7:1-17.
39. Everitt A.R., Clare S., Pertel T., John S.P., Wash R.S., Smith S.E., Chin C.R., Feeley E.M., Sims J.S., Adams D.J., Wise H.M., Kane L., Goulding D., Digard P., Anttila V., Baillie J.K., Walsh T.S., Hume D.A., Palotie A., Xue Y.L., Colonna V., Tyler-Smith C., Dunning J., Gordon S.B., Smyth R.L., Openshaw P.J., Dougan G., Brass A.L., Kellam P. IFITM3 restricts the morbidity and mortality associated with influenza. Nature 2012, 484:519-523.